'Mcf 7' diaporamas de présentation

5-aza-dc - + - + - + - + - + -. CASP8. b- actin. 14. 12. 10. 5-aza-dc - - + + - -. M UM M UM M UM. 8. CASP8. Bisulfite sequence CASP8 promoter. MSP.

Journal Report. Nov15, 2012 Xuyin Zhao. A Multicolor Nanoprobe for Detection and Imaging of Tumor-Related mRNAs in Living Cells Na Li, Chenyang Chang, Wei Pan Angew. Chem. Int. Ed. 2012, 51, 7426 –7430.

CATGGCGATATTGT CATGGCGCCAATAT CATGGCGCGCATTT CATGGCGTGGGGAT CATGGCTAATAAAT CATGGCTCAAGGAG CATGGCTGGACTCC CATGGCTGTGGCCA CATGGCTTTCGTGT CATGGCTTTTTGGC CATGGGAACCGACA CATGGGACCGCCCC CATGGGACCGCTCA CATGGGATCACAAT CATGGGCAACGATC CATGGGCAGCAAGC CATGGGCAGCAATT.

A. BE(2)-C. MCF-7. Calu-6. B. C. BE(2)-C. MCF-7. MRC-5.

APAG-1 DERIVATIVES AS ANTITUMOUR AGENTS.

台灣栽培白英活性成分之研究.

A. B.  E1.  E3. AdGFP. LITR. GFP. RITR. C.  E1.  E3. AdER . D. MCF-7 2,000 particles/cell. LITR. GFP. ER . RITR. AdER  + E2. AdGFP + E2. AdER  No Ligand AdGFP No Ligand. E.

A B C. IC 50 (µM) MCF-7 MLET5 U0126 10.0 (0.75) 8.9 (0.4) LY294002 3.3 (0.04) 0.67 (0.01) . Supplementary Figure 2. EGFR, MAPK and AKT levels and activities in MLET lines, and growth response to specific inhibitors.

A. MDA-MB231. MDA-MB231. MDA-MB231. MCF 7. MCF 7. MCF 7. MsrA. GAPDH. B. MsrA. Sp1. b -actin. b -actin.

Elucidation of Mechanisms of Action of Novel Antitumour Agents. Telomere Targeting Agents (TTAs) Aminoflavone and Benzothiazoles – Aryl hydrocarbon ligand antitumour agents. Targeting Telomeres. Telomeres are repeat sequences of DNA at the end of all chromosomes

Fig. 1 ( Supplementary data). c. 35. PR. ER. 30. 25. 20. RT-qPCR Ct values. 15. 10. 5. 0. HBE. MCF-7. T47-D. a. PR. ER. NC. b. CK18.

U251 MCF-7 A549. - + - - + - - + - scrambled ODN - - + - - + - - + As-miR-221/222. U6. miRNA-221. miRNA-222.

HYPO-7. A. 1 MONTH 6 MONTHS 1 YEAR. B. c. 1 MONTH 6 MONTHS 1 YEAR. HYPO-7. MCF-7 + - + - + - HYPO-7 - + - + - +. DFX 600 m M - +. CA-IX.

Meccanismo di azione e superamento della resistenza ormonale. Novel therapeutic strategies combining antihormonal and targeted approaches. Giuseppe Naso, Roberta Ferraldeschi Oncologia Medica B Università di Roma Sapienza. Endocrine Dependency in Breast Cancer.

A B. Supplementary Figure 3. Transcriptional Co-activator and Co-Repressors Expression in MLET5 Cells.

CATGGCGATATTGT CATGGCGCCAATAT CATGGCGCGCATTT CATGGCGTGGGGAT CATGGCTAATAAAT CATGGCTCAAGGAG CATGGCTGGACTCC CATGGCTGTGGCCA CATGGCTTTCGTGT CATGGCTTTTTGGC CATGGGAACCGACA CATGGGACCGCCCC CATGGGACCGCTCA CATGGGATCACAAT CATGGGCAACGATC CATGGGCAGCAAGC CATGGGCAGCAATT.

靛玉紅衍生物之合成研究及其抗癌作用. 中文摘要

Fig 1. NCI Mean GI 50 graph for NSC 721648, GW 610 (ii). Lung. Colon. Renal Breast. Induction of CYP1A1 mRNA by 5F 203 and GW 610. Fig 2. Fig 3. Resveratrol Incubations. Resveratrol is an inhibitor of CYP1A1 and CYP1B1. HCC 2998 with DF203 or GW610 ± 5uM Resveratrol.

Origin. Origin. MCF-10A. MCF-7. 1. 1. P. P. 2. 2. 5. 5. 3. 3. 4. 4. 6. 6. 7. Solvent System 1. 8. Solvent System 2.

Fig. 2. A. B. 20. 30. BT-474. cells/well. MCF-7. 25. 15. . . 20. 4. . 10. 10. . 15. 10. 5. siRNA1. C. OF. siGFP. siRNA2. siRNA3. 5. 0. 0. G0/G1. G0/G1. 80. S. S. G2/M. G2/M. BT-474. MCF-7. 60. 60. 40. 40. %. %. 20. 20. 0. siRNA1. siRNA1.